Search Results for "vol"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for vol. Results 671 to 680 of 1443 total matches.
Antiviral Drugs
Treatment Guidelines from The Medical Letter • Mar 01, 2013 (Issue 127)
information call: 800-211-2769
Antiviral Drugs
Treatment Guidelines from The Medical Letter • Vol. 11 (Issue ...
The drugs of choice for treatment of viral infections
(other than HIV) and their dosages are listed in Tables
1-6 on the pages that follow. Some of the indications
and dosages recommended here have not been
approved by the FDA. Vaccines used for the prevention
of viral infections are discussed elsewhere.
Cancer Screening
Treatment Guidelines from The Medical Letter • Dec 01, 2012 (Issue 124)
from The Medical Letter • Vol. 10 (Issue 124) • December 2012
Use of screening tests to identify cancers before ...
Use of screening tests to identify cancers before they cause symptoms can lead to earlier therapy and may
improve outcomes. Screening tests for some common
cancers are reviewed below.
Antifungal Drugs
Treatment Guidelines from The Medical Letter • Aug 01, 2012 (Issue 120)
Drugs
62 Treatment Guidelines from The Medical Letter • Vol. 10 ( Issue 120) • August 2012
Table 1 ...
The drugs of choice for treatment of fungal infections
are listed in the table that begins on page 62. Some of
the indications and dosages recommended here have
not been approved by the FDA. More detailed guidelines
for some of these infections are available online
from the Infectious Diseases Society of America
(www.idsociety.org).
Drugs for Tuberculosis
Treatment Guidelines from The Medical Letter • Apr 01, 2012 (Issue 116)
from The Medical Letter • Vol. 10 (Issue 116) • April 2012
These reports include cases of extrapulmonary ...
Tuberculosis (TB) is still a common cause of death
worldwide, and the prevalence of drug-resistant TB
poses challenges to its treatment and control.
Guidelines with detailed management recommendations
are available from the American Thoracic
Society, Centers for Disease Control and Prevention
(CDC) and Infectious Diseases Society of America
(IDSA).
Drugs for Thyroid Disorders
Treatment Guidelines from The Medical Letter • Aug 01, 2009 (Issue 84)
from The Medical Letter • Vol. 7 (Issue 84) August 2009
with 50-100 mcg/day, but others begin with full ...
Primary hypothyroidism is usually the result of Hashimoto's thyroiditis, thyroidectomy for hyperthyroidism, goiter or cancer, or radioactive iodine therapy for hyperthyroidism.
Drugs for Cardiac Arrhythmias
Treatment Guidelines from The Medical Letter • Jun 01, 2007 (Issue 58)
is hemodynamically stable) or DC cardioversion.
Vol. 5 (Issue 58) June 2007
Published by The Medical Letter ...
The drugs of choice for treatment of common cardiac arrhythmias are listed in Tables 1 and 2. Some drugs are recommended for indications that have not been approved by the FDA.
Erythropoietin Safety Concerns
The Medical Letter on Drugs and Therapeutics • May 07, 2007 (Issue 1260)
in Oncology. Cancer- and treatment-related anemia. Vol. 3 2007. Available at www.nccn.org/professionals ...
The erythropoiesis-stimulating agents (ESAs) epoetin alfa (Epogen, Procrit) and darbepoetin alfa (Aranesp) are widely used for treatment of anemia and to reduce the need for red blood cell transfusions. Based on the results of recent clinical trials indicating an increased risk of serious adverse events and death associated with ESAs, particularly when used to achieve a hemoglobin concentration ≥12 g/dL, the FDA has revised the prescribing information for these drugs to include a black box warning.
Pharmaceutical Drug Overdose
Treatment Guidelines from The Medical Letter • Sep 01, 2006 (Issue 49)
or decreased motility.
4
Vol. 4 (Issue 49) September 2006
Published by The Medical Letter, Inc.
1000 ...
Every pharmaceutical drug is a dose-dependent poison. This article describes the clinical presentation and treatment of some dangerous overdoses commonly reported in adults.
Chemotherapy for Esophageal, Gastric and Colorectal Cancers
Treatment Guidelines from The Medical Letter • Aug 01, 2006 (Issue 48)
chemotherapy with 5-FU and cisplatin (FUP) may be the
most widely used, but has substantial toxicity.
Vol. 4 ...
A variety of cancer chemotherapy drugs are used, mostly in combination, for treatment of locally advanced and metastatic esophageal, gastric and colorectal cancers. The mechanism of action, indications and adverse effects of some of these drugs are discussed in thei article.
Raloxifene (Evista) for Breast Cancer Prevention in Postmenopausal Women
The Medical Letter on Drugs and Therapeutics • May 08, 2006 (Issue 1234)
2006 1234 osteoporosis Postmenopausal volume 48 vol. 48 vol 48 treatment of breast cancer Tamoxifen ...
Preliminary results from a new study, unpublished but reported in a press release from the National Cancer Institute and widely disseminated in the public press, suggest that raloxifene (Evista) might be a better choice than tamoxifen (Nolvadex, and others) for prevention of breast cancer in high-risk postmenopausal women.